Journal of the American Medical Association Archives
Heparin, platelets discouraged as treatment for blood clots after COVID vaccine
May. 12, 2021—Heparin and platelets are discouraged as treatment for patients who develop blood clots in the brain and low platelet counts 6-15 days after receiving Johnson & Johnson’s Janssen COVID-19 vaccine, following a clinical investigation review of 12 U.S. cases conducted by the CDC and institutions including Vanderbilt University Medical Center.
Hydroxychloroquine does not help patients hospitalized with COVID-19: Study
Nov. 9, 2020—Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes.
Study finds COVID-19 antibodies drop substantially in the weeks following infection
Sep. 17, 2020—The antibody levels to SAR-CoV-2, the virus that causes COVID-19, substantially drop in the weeks following infection, according to a study led by Vanderbilt University Medical Center and the Centers for Disease Control and Prevention (CDC).
Study finds certain genetic test not useful in predicting heart disease risk
Feb. 27, 2020—A Polygenic Risk Score — a genetic assessment that doctors have hoped could predict coronary heart disease (CHD) in patients — has been found not to be a useful predictive biomarker for disease risk.
Quitting smoking associated with lower risk of cardiovascular disease
Aug. 20, 2019—A new Vanderbilt study documents the great incentive for current smokers to quit.
Sepsis trial ranked No. 1 on critical care website
Feb. 15, 2018—A clinical trial of an intervention for sepsis in patients in Zambia, led by Vanderbilt investigators, topped the list of 2017 trials featured by the website The Bottom Line.
Study shows active surveillance preserves quality of life for prostate cancer patients
Mar. 21, 2017—Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association (JAMA).
Study shows opioids increase risk of death when compared to other pain treatments
Jun. 14, 2016—Long-acting opioids are associated with a significantly increased risk of death when compared with alternative medications for moderate-to-severe chronic pain, according to a Vanderbilt study released today in the Journal of the American Medical Assocation (JAMA).
Guillamondegui: One standard needed to track concussions
Oct. 22, 2015—Data in sports concussion studies will continue to be disputed as long as the injuries are diagnosed by differing standards instead of universal guidelines, a Vanderbilt investigator concludes in a recent review.
Vanderbilt study on spinal cord injuries will guide interventions
Jun. 25, 2015—Traumatic spinal cord injuries are increasing with the population, and incidence is higher in older patients, according to a Vanderbilt study that was published in the Journal of the American Medical Association.
Report calls for new chronic fatigue guidelines
Feb. 12, 2015—An Institute of Medicine committee chaired by Vanderbilt University’s Ellen Wright Clayton, M.D., J.D., on Tuesday called for a new name and new diagnostic criteria for what is familiarly known as chronic fatigue syndrome.
